Tuesday, August 18, 2026
Biotech

Court Rules Against Overseas Drug Imports

A court stopped companies from bringing Gilead drugs into the U.S. from other countries.

Many people with serious diseases need important medicines. These medicines can be very expensive. Some programs tried to help by buying drugs like Gilead's from overseas. They thought this would make the drugs cheaper for patients.

Now, a U.S. appeals court has made a big decision. The court sided with Gilead Sciences. It ruled that these programs cannot bring Gilead's medicines into the country from other places. This means the programs cannot get these drugs at lower prices.

This decision affects how some patients get their medicine. It changes things for programs that help people pay for drugs. The court's ruling makes sure Gilead controls where its medicines are sold in the U.S.

Source: CNBC

#Biotech#Healthcare#Court Ruling

More from Biotech